跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LR-1
首页
药物
LR-1
LR-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Leukemia stem cell targeting ligands and methods of use
US 9334306 B2
申请人: PAN CHONG-XIAN
优先权: 2012
CN
US
4 件公开
Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (MRI) which contain a chelating moiety with polyhydroxylated substituents
US 7988950 B2
申请人: BRACCO IMAGING SPA
优先权: 2004
CN
US
WO
3 件公开
Antigens Targeted by Prevalent Pathogennic T Cells in Type 1 Diabetes and Uses Thereof
US 2008153112 A1
申请人: DILORENZO TERESA P
优先权: 2004
US
2 件公开
BIO-CONJUGATES FOR ONCOLOGY
EP 4480497 A1
申请人: RDP PHARMA AG
优先权: 2023
EP
2 件公开
Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
CN 101052629 A
申请人: OSI PHARM INC
优先权: 2004
CN
Anti-IGF-1R antibodies and uses thereof
CN 101415728 A
申请人: BIOGEN IDEC INC
优先权: 2006
CN
CN 101842117 A
申请人: BIOGEN IDEC INC
优先权: 2008
CN
Microcystin monoclonal antibody and its preparation method and application
CN 101125889 A
申请人: UNIV TSINGHUA
优先权: 2007
CN
Method for separating and purifying microcystin
CN 101585867 B
申请人: JIANGSU ACAD AGRICULTURAL SCI
优先权: 2009
CN
Eukaryotic expression vector for expressing shRNA (short hairpin Ribonucleic Acid) in manner of targeting in cancer cells
CN 101993892 A
申请人: CHANGSHA YINGRUN BIOTECHNOLOGY CO LTD
优先权: 2009
CN
Application of ligand antrum mucosal protein-18(AMP-18) of laminin receptor in treatment of tumor
CN 102827266 A
申请人: BEIJING PROTEIN INNOVATION
优先权: 2011
CN
第 1 / 5 页
上一页
下一页
药物
反馈